A comparative evaluation of gemtuzumab ozogamicin  + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia

Future Oncology, Ahead of Print.

Source: Future Oncology - November 19, 2018 Category: Cancer & Oncology Authors: Ajibade O Ashaye Zarmina Khankhel Yingxin Xu Kyle Fahrbach Ruth Mokgokong Michelle E Orme Kathryn Lang Joseph C Cappelleri Carla Mamolo Source Type: research